Organoids are miniature organs that can be grown in the lab from a person’s stem cells. They can be used to model diseases, and in the future could be used to test drugs or even replace damaged tissue in patients.
But currently organoids are very difficult to grow in a standardized and controlled way, which is key to designing and using them. EPFL scientists have now solved the problem by developing a patent-pending “hydrogel” that provides a fully controllable and tunable way to grow organoids. The breakthrough is published in Nature.
Organoids need a 3D scaffold
Growing organoids begins with stem cells — immature cells that can grow into any cell type of the human body and that play key roles in tissue function and regeneration. To form an organoid, the stem cells are grown inside three-dimensional gels that contain a mix of biomolecules that promote stem cell renewal and differentiation.
The role of these gels is to mimic the natural environment of the stem cells, which provides them with a protein- and sugar-rich scaffold called the “extracellular matrix”, upon which the stem cells build specific body tissues. The stem cells stick to the extracellular matrix gel, and then “self-organize” into miniature organs like retinas, kidneys, or the gut. These tiny organs retain key aspects of their real-life biology, and can be used to study diseases or test drugs before moving on to human trials.
But the current gels used for organoid growth are derived from mice, and have problems. First, it is impossible to control their makeup from batch to batch, which can cause stem cells to behave inconsistently. Second, their biochemical complexity makes them very difficult to fine-tune for studying the effect of different parameters (e.g. biological molecules, mechanical properties, etc.) on the growth of organoids. Finally, the gels can carry pathogens or immunogens, which means that they are not suitable for growing organoids to be used in the clinic.
A hydrogel solution
The lab of Matthias Lütolf at EPFL’s Institute of Bioengineering has developed a synthetic “hydrogel” that eschews the limitations of conventional, naturally derived gels. The patent-pending gel is made of water and polyethylene glycol, a substance used widely today in various forms, from skin creams and toothpastes to industrial applications and, as in this case, bioengineering.
Nikolce Gjorevski, the first author of the study, and his colleagues used the hydrogel to grow stem cells of the gut into a miniature intestine. The functional hydrogel was not only a goal in and of itself, but also a means to identify the factors that influence the stem cells’ ability to expand and form organoids. By carefully tweaking the hydrogel’s properties, they discovered that separate stages of the organoid formation process require different mechanical environments and biological components.
One such factor is a protein called fibronectin, which helps the stem cells attach to the hydrogel. Lütolf’s lab found that this attachment itself is immensely important for growing organoids, as it triggers a whole host of signals to the stem cell that tell it to grow and build an intestine-like structure. The researchers also discovered an essential role for the mechanical properties, i.e. the physical stiffness, of the gel in regulating intestinal stem cell behavior, shedding light on how cells are able to sense, process and respond to physical stimuli. This insight is particularly valuable – while the influence of biochemical signals on stem cells is well-understood, the effect of physical factors has been more mysterious.
Because the hydrogel is man-made, it is easy to control its chemical composition and key properties, and ensure consistency from batch to batch. And because it is artificial, it does not carry any risk of infection or triggering immune responses. As such, it provides a means of moving organoids from basic research to actual pharmaceutical and clinical applications in the future.
Lütolf’s lab is now researching other types of stem cells in order to extend the capacities of their hydrogel into other tissues.
Learn more: Taking miniature organs from lab to clinic
The Latest on: Organoids
[google_news title=”” keyword=”organoids” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Organoids
- Global Organoids and Spheroids Market: Journey to US$4,567.0 Million Revenue by 2031on May 8, 2024 at 12:45 am
Global Organoids and Spheroids Market was valued at US$ 771.4 million in 2022 and is projected to attain a valuation of US$ 4,567.0 Million by 2031 at a CAGR of 22.42% During the Forecast Period ...
- Human Organoids Market CAGR of 17.5%, Big Money to be Made as Market Size Continues to Surgeon May 5, 2024 at 3:05 pm
Human Organoids Market is valued approximately at USD 723.40 million in 2019 and is anticipated to grow with a healthy growth rate of more than 17.5% over the forecast period 2020-2027. Organoids are ...
- Fetal Organoids Generated From Human Amniotic Fluidon May 2, 2024 at 5:00 pm
Over the last decade, organoids have become an increasingly popular platform for modeling organ function and disease. 3 However, the generation of fetal organoids is complicated by ethical and legal ...
- Scientists develop new organoid model to study thymus functionon April 29, 2024 at 8:08 am
Researchers from the Organoid group have developed a new organoid model that can be used to study the thymus. The organoids are derived from mouse thymus tissue, specifically model thymic epithelial ...
- Lab-made miniorgans take scientists a step closer to curing canceron April 25, 2024 at 8:34 am
In the fight to cure cancer, scientists need better models. And they might just get them — human-derived organoids — thanks to light.
- Brain organoids target rare neurological disorderon April 24, 2024 at 8:00 am
Scientists have devised a potential therapy for a rare neurological disease using brain tissue derived from human stem cells, raising hopes that so-called organoid technology can target other ...
- Brain organoids target rare neurological disorderon April 23, 2024 at 5:00 pm
The researchers transplanted so-called brain organoids derived from the stem cells of Timothy syndrome sufferers into the brains of young rats, according to results published in Nature on Wednesday.
- Mini-colon and brain ‘organoids’ shed light on cancer and other diseaseson April 23, 2024 at 5:00 pm
When the researchers injected the cancerous cells into mice, the tumours looked similar to those seen in human colorectal cancer. The organoids accumulated fewer tumours when the researchers ...
- Human Lung Organoids Mimic Animal Response to Nanomaterialson April 17, 2024 at 5:00 pm
Though not expected to replace animal models completely, human organoids could soon lead to significant reductions in research animal numbers, the team led by cell biologist and nanotoxicologist Dr ...
via Bing News